Would be nice to see another update from the Management team.
"Testing for osteogenic differentiation revealed enhanced osteogenic
differentiation capabilities.
The project is now set to advance to in vivo studies of biological models, to gauge
the efficacy of bone regeneration.
“While we continue to prioritise our objective of commercialising our current products, we are
looking forward to working on new technologies – such as the next-generation jaw implant –
which supports our long-term vision of becoming the global leader in regenerative medicine,”
said Dr Lim.
The global dental bone graft and membrane substitutes market was valued at USD$11.47
billion in 2023, with a projected value of USD$27.55 billion by 2030."
Would be nice to see another update from the Management...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.001(2.33%) |
Mkt cap ! $4.853M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.3¢ | 4.2¢ | $11.18K | 265.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 293354 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 203857 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| OSX (ASX) Chart |